Published in Antimicrob Agents Chemother on April 01, 1992
Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiol Mol Biol Rev (2001) 9.14
Bacterial resistance to tetracycline: mechanisms, transfer, and clinical significance. Clin Microbiol Rev (1992) 3.51
Acquired antibiotic resistance genes: an overview. Front Microbiol (2011) 2.80
Ribosomal protection proteins and their mechanism of tetracycline resistance. Antimicrob Agents Chemother (2003) 1.70
Mechanism of action of the novel aminomethylcycline antibiotic omadacycline. Antimicrob Agents Chemother (2013) 1.39
A novel glycylcycline, 9-(N,N-dimethylglycylamido)-6-demethyl-6-deoxytetracycline, is neither transported nor recognized by the transposon Tn10-encoded metal-tetracycline/H+ antiporter. Antimicrob Agents Chemother (1995) 1.05
Natural and synthetic tetracycline-inducible promoters for use in the antibiotic-producing bacteria Streptomyces. Nucleic Acids Res (2005) 1.01
tRNA modification activity is necessary for Tet(M)-mediated tetracycline resistance. J Bacteriol (1993) 0.89
Tetracycline analogs whose primary target is not the bacterial ribosome. Antimicrob Agents Chemother (1994) 0.88
Tetracycline hypersensitivity of an ezrA mutant links GalE and TseB (YpmB) to cell division. Front Microbiol (2015) 0.75
pBR322 vectors having tetracycline-dependent replication. Plasmid (2016) 0.75
Properties of a cryptic high-frequency transducing phage in Staphylococcus aureus. Virology (1967) 14.24
Heterogeneity of tetracycline resistance determinants. Plasmid (1980) 6.42
Heterogeneity of tetracycline resistance determinants in Streptococcus. J Bacteriol (1982) 6.20
Nucleotide sequence of the tetM tetracycline resistance determinant of the streptococcal conjugative shuttle transposon Tn1545. Nucleic Acids Res (1986) 4.47
Incompatibility and molecular relationships between small Staphylococcal plasmids carrying the same resistance marker. Plasmid (1978) 3.30
New perspectives in tetracycline resistance. Mol Microbiol (1990) 2.14
A variety of Staphylococcal plasmids present as multiple copies. J Gen Microbiol (1973) 1.85
Molecular basis of tetracycline action: identification of analogs whose primary target is not the bacterial ribosome. Antimicrob Agents Chemother (1991) 1.69
Gene heterogeneity for tetracycline resistance in Staphylococcus spp. Antimicrob Agents Chemother (1990) 1.60
Chelocardin-inducible resistance in Escherichia coli bearing R plasmids. Antimicrob Agents Chemother (1976) 1.25
Resistance to various tetracyclines mediated by transposon Tn10 in Escherichia coli K-12. Antimicrob Agents Chemother (1985) 1.03
Antibacterial activity of a new thiatetracycline antibiotic, thiacycline, in comparison with tetracycline, doxycycline and minocycline. J Antimicrob Chemother (1982) 0.97
Effects of tetracyclines on the production of extracellular proteins by members of the propionibacteriaceae. FEMS Microbiol Lett (1989) 0.83
Bacterial resistance to the tetracyclines. Microbiol Rev (1978) 2.52
The tetracyclines: prospects at the beginning of the 1980s. J Antimicrob Chemother (1981) 2.33
Genetic studies of a multi-resistant strain of Staphylococcus aureus. J Med Microbiol (1974) 2.19
Plasmid-mediated tetracycline resistance in Escherichia coli involves increased efflux of the antibiotic. Biochem Biophys Res Commun (1980) 1.98
Joint tolerance to beta-lactam and fluoroquinolone antibiotics in Escherichia coli results from overexpression of hipA. Antimicrob Agents Chemother (1998) 1.92
Molecular basis of beta-lactamase induction in bacteria. Antimicrob Agents Chemother (1993) 1.89
A variety of Staphylococcal plasmids present as multiple copies. J Gen Microbiol (1973) 1.85
Mechanisms of resistance to fusidic acid in Staphylococcus aureus. J Gen Microbiol (1976) 1.81
Evidence for more than one mechanism of plasmid-determined tetracycline resistance in Escherichia coli. J Gen Microbiol (1980) 1.80
Organic acids: chemistry, antibacterial activity and practical applications. Adv Microb Physiol (1991) 1.78
Mechanism of plasmic-mediated resistance to cadmium in Staphylococcus aureus. Antimicrob Agents Chemother (1975) 1.72
Molecular basis of tetracycline action: identification of analogs whose primary target is not the bacterial ribosome. Antimicrob Agents Chemother (1991) 1.69
Transport of antibiotics into bacteria. Adv Microb Physiol (1982) 1.62
Decreased uptake of cadmium by a resistant strain of Staphylococcus aureus. J Gen Microbiol (1970) 1.60
Diffusion of tetracycline across the outer membrane of Escherichia coli K-12: involvement of protein Ia. Biochem Biophys Res Commun (1978) 1.55
Molecular genetic and structural modeling studies of Staphylococcus aureus RNA polymerase and the fitness of rifampin resistance genotypes in relation to clinical prevalence. Antimicrob Agents Chemother (2006) 1.54
Analysis of tetracycline resistance encoded by transposon Tn10: deletion mapping of tetracycline-sensitive point mutations and identification of two structural genes. J Bacteriol (1983) 1.53
Evidence that tetracycline analogs whose primary target is not the bacterial ribosome cause lysis of Escherichia coli. Antimicrob Agents Chemother (1992) 1.53
Tetracycline resistance genes from Bacillus plasmid pAB124 confer decreased accumulation of the antibiotic in Bacillus subtilis but not in Escherichia coli. J Bacteriol (1981) 1.52
Characterization of the epidemic European fusidic acid-resistant impetigo clone of Staphylococcus aureus. J Clin Microbiol (2007) 1.49
Reduced expression of Tn 10-mediated tetracycline resistance in Escherichia coli containing more than one copy of the transposon. J Gen Microbiol (1981) 1.48
Genetic basis of resistance to fusidic acid in staphylococci. Antimicrob Agents Chemother (2007) 1.48
Effect of short-chain organic acids on macromolecular synthesis in Escherichia coli. J Appl Bacteriol (1990) 1.41
Tetracycline resistance determinants from groups A to D vary in their ability to confer decreased accumulation of tetracycline derivatives by Escherichia coli. J Gen Microbiol (1982) 1.40
Antimicrobial activity and mechanisms of resistance to cephalosporin P1, an antibiotic related to fusidic acid. J Antimicrob Chemother (2002) 1.33
Leakage of periplasmic proteins from Escherichia coli mediated by polymyxin B nonapeptide. Antimicrob Agents Chemother (1986) 1.33
RNA polymerase inhibitors with activity against rifampin-resistant mutants of Staphylococcus aureus. Antimicrob Agents Chemother (2000) 1.31
Antimicrobial properties and mode of action of the pyrrothine holomycin. Antimicrob Agents Chemother (2001) 1.31
Comparison of the polypeptide composition of Escherichia coli outer membranes prepared by two methods. J Bacteriol (1980) 1.29
Mutation frequencies for resistance to fusidic acid and rifampicin in Staphylococcus aureus. J Antimicrob Chemother (2001) 1.25
Biochemical and genetic basis of tetracycline resistance in Staphylococcus aureus. Antimicrob Agents Chemother (1974) 1.20
Increased mutability of Pseudomonas aeruginosa in biofilms. J Antimicrob Chemother (2008) 1.20
Penicillin-binding protein 2 is required for induction of the Citrobacter freundii class I chromosomal beta-lactamase in Escherichia coli. Antimicrob Agents Chemother (1989) 1.20
Short-chain organic acids at ph 5.0 kill Escherichia coli and Salmonella spp. without causing membrane perturbation. J Appl Bacteriol (1991) 1.17
Effect of plasmid carriage on the virulence of staphylococcus aureus. J Med Microbiol (1975) 1.16
Bacterial resistance mechanisms as therapeutic targets. J Antimicrob Chemother (1994) 1.09
Induction of tetracycline resistance in Staphylococcus aureus in the absence of lipid synthesis. J Gen Microbiol (1975) 1.08
Towards new business models for R&D for novel antibiotics. Drug Resist Updat (2011) 1.08
Polymyxin B and polymyxin B nonapeptide alter cytoplasmic membrane permeability in Escherichia coli. J Antimicrob Chemother (1986) 1.08
SB 205952, a novel semisynthetic monic acid analog with at least two modes of action. Antimicrob Agents Chemother (1995) 1.07
Expression of the Staphylococcus aureus UDP-N-acetylmuramoyl- L-alanyl-D-glutamate:L-lysine ligase in Escherichia coli and effects on peptidoglycan biosynthesis and cell growth. J Bacteriol (1999) 1.07
Resistance to beta-lactams in Mycobacterium fortuitum. Antimicrob Agents Chemother (1992) 1.06
Distribution of fusidic acid resistance determinants in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (2010) 1.06
High prevalence of resistance to fusidic acid in clinical isolates of Staphylococcus epidermidis. J Antimicrob Chemother (2008) 1.05
Evidence for mutation to streptomycin resistance in clinical strains of Staphylococcus aureus. J Gen Microbiol (1972) 1.05
Lysozyme-promoted association of protein I molecules in the outer membrane of Escherichia coli. J Bacteriol (1977) 1.05
Genetic analysis of the tetA(C) gene on plasmid pBR322. J Bacteriol (1992) 1.01
Emergence and maintenance of resistance to fluoroquinolones and coumarins in Staphylococcus aureus: predictions from in vitro studies. J Antimicrob Chemother (2007) 1.01
Mutations affecting penicillin-binding proteins 2a, 2b and 3 in Bacillus subtilis alter cell shape and peptidoglycan metabolism. J Gen Microbiol (1987) 0.98
The antibacterial effects of low concentrations of antibiotics. Adv Microb Physiol (1986) 0.98
Stabilization of Rhizobium symbiosis plasmids. Microbiology (1999) 0.97
Accumulation of tetracyclines by Escherichia coli K-12. Biochem Biophys Res Commun (1977) 0.97
Energetics of tetracycline transport into Escherichia coli. Antimicrob Agents Chemother (1984) 0.93
Affinities of beta-lactams for penicillin binding proteins of Chlamydia trachomatis and their antichlamydial activities. Antimicrob Agents Chemother (2001) 0.91
Biochemical and genetic characterization of the tet determinant of Bacillus plasmid pAB124. J Bacteriol (1984) 0.90
Inhibition of Escherichia coli K12 by short-chain organic acids: lack of evidence for induction of the SOS response. J Appl Bacteriol (1991) 0.88
Antibacterial activity and mode of action of tert-butylhydroquinone (TBHQ) and its oxidation product, tert-butylbenzoquinone (TBBQ). J Antimicrob Chemother (2013) 0.87
Delayed postoperative intracerebral abscess caused by Proprionibacterium acnes: case report and review of the literature. Br J Neurosurg (2003) 0.87
Origin of tetracycline efflux proteins: conclusions from nucleotide sequence analysis. Mol Microbiol (1991) 0.86
Antibiotic resistance resulting from decreased drug accumulation. Br Med Bull (1984) 0.86
Limitations of a fluorescence assay for studies on tetracycline transport into Escherichia coli. Antimicrob Agents Chemother (1983) 0.84
Outer membrane composition in Escherichia coli and the poor activity of hydrophobic antibiotics against enteric bacteria. J Antimicrob Chemother (1982) 0.83
Uptake of tetracycline by Escherichia coli is not mediated by the sodium dependent glutamate transport system. J Antimicrob Chemother (1990) 0.83
Mode of action of the cyclic depsipeptide antibiotic LL-AO341 beta 1 and partial characterization of a Staphylococcus aureus mutant resistant to the antibiotic. J Antimicrob Chemother (1993) 0.83
Induction of the Citrobacter freundii group I beta-lactamase in Escherichia coli is not dependent on entry of beta-lactam into the cytoplasm. Antimicrob Agents Chemother (1990) 0.82
Use of mutator strains for characterization of novel antimicrobial agents. Antimicrob Agents Chemother (2001) 0.82
Cytokines modulate type I iodothyronine deiodinase mRNA levels and enzyme activity in FRTL-5 rat thyroid cells. Mol Cell Endocrinol (1994) 0.81
Intradural metastatic spinal cord compression from ACTH-secreting pituitary carcinoma. Acta Neurochir (Wien) (2004) 0.81
Inhibition of Providencia stuartii cell envelope enzymes by chlorhexidine. J Antimicrob Chemother (1987) 0.80
Inhibition of beta-lactamase synthesis in Staphylococcus aureus by minocycline. J Antimicrob Chemother (1985) 0.80
Transcriptional signature following inhibition of early-stage cell wall biosynthesis in Staphylococcus aureus. Antimicrob Agents Chemother (2009) 0.80
Susceptibility of protein synthesis in Escherichia coli to tetracycline and minocycline. J Gen Microbiol (1981) 0.79
Lack of correlation between methicillin resistance and susceptibility to lysostaphin in Staphylococcus aureus. J Gen Microbiol (1974) 0.79
Haemangioblastoma: a rare cause of a cerebellar mass in the elderly. Br J Neurosurg (2003) 0.79
Antibacterial spectra of drugs used for chemotherapy of mycobacterial infections. Tuber Lung Dis (1998) 0.78
Genetic and biochemical basis of tetracycline resistance. J Antimicrob Chemother (1986) 0.78
Transport of tetracyclines into Escherichia coli requires a carboxamide group at the C2 position of the molecule. J Antimicrob Chemother (1986) 0.78
Tetracycline resistance in Escherichia coli K12 is not associated with a decrease in cyclopropane fatty acid content. J Gen Microbiol (1977) 0.77
Plasmid-determined tetracycline resistance in Escherichia coli K12: lack of evidence that resistance is related to changes in lipid metabolism [proceedings]. Biochem Soc Trans (1978) 0.77
Inhibition of K88-mediated adhesion of Escherichia coli to mammalian receptors by antibiotics that affect bacterial protein synthesis. J Antimicrob Chemother (1986) 0.77
An assay to detect inhibitors of bacterial iron transport. J Antibiot (Tokyo) (1994) 0.77
Triiodothyronine (T3) reflects renal graft function after renal transplantation. Clin Endocrinol (Oxf) (1997) 0.76
Pilocytic astrocytoma mimicking craniopharyngioma: a case series. Ann R Coll Surg Engl (2012) 0.75
Paradoxical response and tolerance in a strain of Staphylococcus aureus. J Antimicrob Chemother (1994) 0.75
The significance of triiodothyronine. Calif Med (1973) 0.75
Antibiotics and bacterial adhesion. J Antimicrob Chemother (1986) 0.75
Inhibition of staphylococcal growth by fusidic acid prevents production of volatile metabolites. J Antimicrob Chemother (2000) 0.75
Inhibition of K88ab-mediated haemagglutination by polymyxin B nonapeptide. J Antimicrob Chemother (1991) 0.75
Multiple isoelectric forms of bacterial penicillin-binding proteins: artefacts or genuine cellular components? J Antimicrob Chemother (1988) 0.75
Prediction of signal sequence-dependent protein translocation in bacteria: assessment of the Escherichia coli minicell system. Biochem Biophys Res Commun (1988) 0.75
Loose cilium in meibomian gland: mimicking early postoperative endophthalmitis. Eye (Lond) (2006) 0.75